Bird and Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case Bird & Bird acted for Ratiopharm, a Teva subsidiary, with litigators Oliver Jüngst and Annika Lückemann working alongside patent attorney Anne Halbach … Read More at Source. Author: Pumilo Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook More Share on LinkedIn (Opens in new window) LinkedIn Share on Reddit (Opens in new window) Reddit Share on Tumblr (Opens in new window) Tumblr Share on Pinterest (Opens in new window) Pinterest Share on Telegram (Opens in new window) Telegram Share on WhatsApp (Opens in new window) WhatsApp Like this:Like Loading… Related Tags: BirdNews August 1, 2025 by Pumilo Bird News 0
